Clinical Trials Logo

Tachycardia Atrial clinical trials

View clinical trials related to Tachycardia Atrial.

Filter by:
  • None
  • Page 1

NCT ID: NCT06376916 Recruiting - Atrial Fibrillation Clinical Trials

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

ATRIUM
Start date: June 2024
Phase: Phase 3
Study type: Interventional

The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.

NCT ID: NCT04198220 Completed - Atrial Fibrillation Clinical Trials

BIO|STREAM.ICM Obesity

Start date: September 17, 2020
Phase:
Study type: Observational

The aim of the submodule study is to assess whether a high BMI may influence the sensing performance and the sECG quality of the BIOMONITOR.

NCT ID: NCT03376438 Recruiting - Atrial Flutter Clinical Trials

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

FAST Registry
Start date: June 8, 2017
Phase:
Study type: Observational

The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.